Molecular Partners and Orano Med expand collaboration to develop ten 212Pb-Radio-DARPin therapy candidates, initiating clinical trials in 2025. Molecular Partners AG and Orano Med have expanded their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results